Is mild cognitive impairment in Parkinson’s disease a useful diagnosis?

Is mild cognitive impairment in Parkinson’s disease a useful diagnosis?

The question is one of neurology’s many enduring and intriguing debates. At the AAT-AD/PD Focus meeting, Amos Korczyn (Tel Aviv University, Israel) was clear the answer is “No”. The problematic basis for a diagnosis of mild cognitive impairment, its uncertain prognostic implications, and the adverse impact it may have on patients makes the concept unsuited for clinical use. Do you agree?

02:54
Download

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References

1. Goldman AG, Litvan I. Minerva Med 2011;102:441-59

2. Weil RS, et al. Curr Neurol Neurosci 2018;18:17

3. Palavra N, et al. Neurology Research Int 2013;ID 576091

4. Cammisuli DM, et al. Front. Aging Neurosci; 2019 Nov 8

5. Korczyn AD. Parkinsonism Relat Disord 2016;22 1:S159-61

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country